Medical Care Technologies, Inc. Appoints Key Member to Its Advisory Board
January 11 2010 - 4:48PM
Marketwired
Medical Care Technologies, Inc. (OTCBB: MDCE) today announced that
Minh Nguyen was elected as an Advisory Board Member to the Company.
Ms. Nguyen brings extensive knowledge of business, as well as
experience in several industries, including international business
trade, and products. Ms. Nguyen has more than 17 years of
experience in start-ups and management.
Ms. Nguyen graduated from Hanoi Foreign Languages University in
English and French Studies in 1992 and Business and Finance
Management from Hanoi Economic University in 1994.
Ms. Nguyen started out her career working as a Business
Coordinator for the Vietnam Chamber of Commerce in Hanoi
(1992-1994), assisting Vietnamese business enterprises in
maintaining trade relations with other countries. Ms. Nguyen was
responsible for promoting and protecting Vietnamese businesses and
their interests in Vietnam as well as abroad. Her other
responsibilities included promoting and assisting in their trade
and investment, their economic and technological co-operation, as
well as other business activities in Vietnam and abroad.
From 1995-2000, Ms. Nguyen took on the role of Director of Hanoi
Trading Company of Hanoi, Vietnam. Her responsibilities included
supervising and coordinating activities of workers engaged in
inspecting materials to ensure adherence to the company's quality
standards and customer specifications.
From 2000-2005, Ms. Nguyen was an independent consultant and
imported and exported textile products between China and Vietnam.
Located in Hanoi, she served as the business liaison for businesses
in Shanghai, China and Hanoi, Vietnam.
From 2005-2008, Ms. Nguyen was an independent consultant, acting
as the liaison for tourism and trade between Vietnam and Europe.
Based in Shanghai, her responsibilities included launching trade
and tourism promotions, meeting local officials, businesses and
overseas Vietnamese to introduce trade and investment opportunities
in Vietnam.
Ms. Nguyen's expertise includes all sectors of the economy
(import-export, public service, textiles and manufacturing, real
estate, technology, and retail and wholesale). She is fluent in
English, Vietnamese, French and Mandarin and conversational in
Russian.
"We are pleased to welcome Ms. Nguyen to our Advisory Board,"
said Patricia Traczykowski, President of MDCE. "Her insights and
access to the Vietnam market for our technology, products and
services will be valuable as MDCE plans to expand and grow the
Company in other markets outside of China. We look forward to
working with her."
About Medical Care Technologies, Inc.
Medical Care Technologies, Inc. (www.medicaretech.com) is traded
under the symbol MDCE on the OTCBB and is based in London, England.
The Company is in the process of moving its portfolio of oil
resources into medical care technologies. The products/services
that the company hopes to acquire are intended will constitute a
healthcare delivery and wellness site; dedicated to helping Asian
consumers live healthier, more balanced lives. MDCE is planning to
provide advanced connectivity, internationally standardized and
secure business, technology and information systems to assist the
Asian health industry -- physicians, pharmacists, medical
institutions, consumers -- access medical resources, health
services, education, wellness and pharmaceutical products
throughout Asia. MDCE is planning to distribute and provide
services at a diverse range of industry-leading product lines in
three segments: Medical Devices, Pharmaceuticals and
Nutriceuticals. Further information on the Company can be found at
www.sec.gov and the company's website at www.medicaretech.com
Safe Harbor Statement
All statements contained in this press release, other than
statements of historical fact, are forward-looking statements,
including those regarding: MDCE's products, services, capabilities,
performance, opportunities, development and business outlook,
guidance on our future financial results and other projections or
measures of our future performance; the amount and timing of the
benefits expected from strategic initiatives and acquisitions or
from deployment of new or updated technologies, products, services
or applications; and other potential sources of additional revenue.
These statements are based on our current plans and expectations
and involve risks and uncertainties that could cause actual future
events or results to be different than those described in or
implied by such forward-looking statements. These risks and
uncertainties include those relating to: lack of operating history,
transitioning from a development company to an operating company,
difficulties in distinguishing MDCE's products and services,
ability to deploy MDCE's services and products, market acceptance
of our products and services; operational difficulties relating to
combining acquired companies and businesses; our ability to form
and maintain mutually beneficial relationships with customers and
strategic partners; changes in economic, political or regulatory
conditions or other trends affecting the healthcare, Internet,
information technology and healthcare and pharmaceutical
industries, and our ability to attract and retain qualified
personnel. Other risks and uncertainties may include, but are not
limited to: lack of or delay in market acceptance and fluctuations
in customer demand, dependence on a limited number of significant
customers, reliance on third party vendors and strategic partners,
ability to meet future capital requirements on acceptable terms,
continuing uncertainty in the global economy, and compliance with
federal and state regulatory requirement. Further information about
these matters can be found in our Securities and Exchange
Commission filings. We expressly disclaim any intent or obligation
to update these forward-looking statements. There can be no
assurance that the acquisition of GUC's assets will close. MDCE
must issue 57,300,000 shares of its common stock to GUC, or GUC's
designees in order to close the acquisition. Accounting for the
anticipated cancelation of 57,300,000 shares by Patricia
Traczykowski, MDCE will have 98,900,000 shares of its common stock
issued and outstanding upon the closing of the acquisition.
For Further Information: Ezra Smith C. Jones Consulting, Inc.
Tel: (727) 771-9500 Fax: (727) 771-9545 Email:
cjones@cjonesconsulting.com Web: www.cjonesconsulting.com
Medical Care Technologies (PK) (USOTC:MDCE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medical Care Technologies (PK) (USOTC:MDCE)
Historical Stock Chart
From Jul 2023 to Jul 2024